Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion

(Reuters) - Botox maker Allergan Plc <AGN.N,> agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.